{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:31Z","timestamp":1764402511873},"reference-count":50,"publisher":"Japanese Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2011]]},"DOI":"10.1538\/expanim.60.93","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T06:07:00Z","timestamp":1303366020000},"page":"93-100","source":"Crossref","is-referenced-by-count":8,"title":["An Experimental Mouse Model for Hepatitis C Virus"],"prefix":"10.1538","volume":"60","author":[{"given":"Kiminori","family":"KIMURA","sequence":"first","affiliation":[{"name":"Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science"},{"name":"Division of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"KOHARA","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Alter, H.J. 2005. HCV natural history: the retrospective and prospective in perspective. J. Hepatol. 43: 550–552.","DOI":"10.1016\/j.jhep.2005.07.002"},{"issue":"3","key":"2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","volume":"120","author":"BISSIG KARL-DIMITER","year":"2010","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bukh, J. 2004. A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39: 1469–1475.","DOI":"10.1002\/hep.20268"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119308"},{"key":"5","unstructured":"5. Chisari, F.V. 2000. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156: 1117–1132."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80044-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., Lascar, R.M., Brown, D., Gilson, R.J., Tedder, R.J., Dusheiko, G.M., Jacobs, M., Klenerman, P., and Maini, M.K. 2009. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289–1300.","DOI":"10.1053\/j.gastro.2009.06.054"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dustin, L.B. and Rice, C.M. 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25: 71–99.","DOI":"10.1146\/annurev.immunol.25.022106.141602"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1038\/nature04078"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Golden-Mason, L., Madrigal-Estebas, L., McGrath, E., Conroy, M.J., Ryan, E.J., Hegarty, J. E., O'Farrelly, C., and Doherty, D.G. 2008. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57: 1121–1128.","DOI":"10.1136\/gut.2007.130963"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gottwein, J.M., Scheel, T.K., Jensen, T.B., Lademann, J.B., Prentoe, J.C., Knudsen, M.L., Hoegh, A.M., and Bukh, J. 2009. Development and characterization of hepatitis C virus genotype 1–7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 364–377.","DOI":"10.1002\/hep.22673"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088774"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Guidotti, L.G. and Chisari, F.V. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1: 23–61.","DOI":"10.1146\/annurev.pathol.1.110304.100230"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21587"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaech, S.M. and Ahmed, R. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2: 415–422.","DOI":"10.1038\/87720"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)01139-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kaech, S.M., Wherry, E.J., and Ahmed, R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251–262.","DOI":"10.1038\/nri778"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.921"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kasama, Y., Sekiguchi, S., Saito, M., Tanaka, K., Satoh, M., Kuwahara, K., Sakaguchi, N., Takeya, M., Hiasa, Y., Kohara, M., and Tsukiyama-Kohara, K. 2010. Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood 116: 4926–4933","DOI":"10.1182\/blood-2010-05-283358"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kern, M., Popov, A., Kurts, C., Schultze, J.L., and Knolle, P.A. 2010. Taking off the brakes: T cell immunity in the liver. Trends Immunol. 31: 311–317.","DOI":"10.1016\/j.it.2010.06.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kimura, K., Kakimi, K., Wieland, S., Guidotti, L.G., and Chisari, F.V. 2002. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J. Immunol. 169: 5188–5195.","DOI":"10.4049\/jimmunol.169.9.5188"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.10702-10707.2002"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.1.57"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lassen, M.G., Lukens, J.R., Dolina, J.S., Brown, M.G., and Hahn, Y.S. 2010. Intrahepatic IL-10 maintains NKG2A+Ly49– liver NK cells in a functionally hyporesponsive state. J. Immunol. 184: 2693–2701.","DOI":"10.4049\/jimmunol.0901362"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450107"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A.W., Stamataki, Z., Gastaminza, P., Chisari, F.V., Jones, I.M., Fox, R.I., Ball, J.K., McKeating, J.A., Kneteman, N.M., and Burton, D.R. 2008. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14: 25–27.","DOI":"10.1038\/nm1698"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010137200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Machida, K., Tsukiyama-Kohara, K., Sekiguch, S., Seike, E., Tone, S., Hayashi, Y., Tobita, Y., Kasama, Y., Shimizu, M., Takahashi, H., Taya, C., Yonekawa, H., Tanaka, N., and Kohara, M. 2009. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins. Gastroenterology 137: 285–296","DOI":"10.1053\/j.gastro.2009.03.061"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Maini, M.K., Boni, C., Ogg, G.S., King, A.S., Reignat, S., Lee, C.K., Larrubia, J.R., Webster, G.J., McMichael, A.J., Ferrari, C., Williams, R., Vergani, D., and Bertoletti, A. 1999. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 117: 1386–1396.","DOI":"10.1016\/S0016-5085(99)70289-1"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.19.12365-12374.2005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mercer, D.F., Schiller, D.E., Elliott, J.F., Douglas, D.N., Hao, C., Rinfret, A., Addison, W.R., Fischer, K.P., Churchill, T.A., Lakey, J.R., Tyrrell, D.L., and Kneteman, N.M. 2001. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7: 927–933.","DOI":"10.1038\/90968"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Meuleman, P., Hesselgesser, J., Paulson, M., Vanwolleghem, T., Desombere, I., Reiser, H., and Leroux-Roels, G. 2008. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48: 1761–1768.","DOI":"10.1002\/hep.22547"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Meuleman, P. and Leroux-Roels, G. 2008. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV. Antiviral. Res. 80: 231–238.","DOI":"10.1016\/j.antiviral.2008.07.006"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.6861"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pawlotsky, J.M. 2004. Treating hepatitis C in “difficult-to-treat” patients. N. Engl. J. Med. 351: 422–423.","DOI":"10.1056\/NEJMp048068"},{"key":"36","unstructured":"36. Pawlotsky, J.M. and McHutchison, J.G. 2004. Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003. Hepatology 39: 554–567."},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2009.223"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.1047"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Rui, L. and Goodnow, C.C. 2006. Lymphoma and the control of B cell growth and differentiation. Curr. Mol. Med. 6: 291–308.","DOI":"10.2174\/156652406776894563"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141122"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Satoh, K., Takahashi, H., Matsuda, C., Tanaka, T., Miyasaka, M., Zeniya, M., and Kohara, M. 2010. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice. J. Med. Virol. 82: 1545–1553.","DOI":"10.1002\/jmv.21859"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Shepard, C.W., Finelli, L., and Alter, M.J. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5: 558–567.","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030239"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360729"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., Asahara, T., Yokoi, T., Furukawa, T., and Yoshizato, K. 2004. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 165: 901–912.","DOI":"10.1016\/S0002-9440(10)63352-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Tellinghuisen, T.L. and Rice, C.M. 2002. Interaction between hepatitis C virus proteins and host cell factors. Curr. Opin. Microbiol. 5: 419–427.","DOI":"10.1016\/S1369-5274(02)00341-7"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.10.1395"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.15.9001"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9506"},{"key":"50","unstructured":"50. Zou, S., Dodd, R.Y., Stramer, S.L., and Strong, D.M. 2004. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N. Engl. J. Med. 351: 751–759."}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/expanim\/60\/2\/60_2_93\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T08:28:58Z","timestamp":1618820938000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/expanim\/60\/2\/60_2_93\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.60.93","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}